Avidity Biosciences (RNA) Institutional Ownership

Of the 324 institutional investors that purchased Avidity Biosciences' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Wellington Management Group LLP ($6.70M), Balyasny Asset Management L.P. ($6.04M), Pentwater Capital Management LP ($6.01M), Norges Bank ($4.77M), Vanguard Group Inc. ($4.61M), HBK Investments L P ($4.37M), and Janus Henderson Group PLC ($3.40M).

Institutional investors have bought a total of 65,528,603 shares in the last 24 months. This purchase volume represents approximately $4.13B in transactions.

Of the 93 institutional investors that sold Avidity Biosciences' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Price T Rowe Associates Inc. MD ($9.64M), Wellington Management Group LLP ($9.34M), Janus Henderson Group PLC ($7.58M), Avoro Capital Advisors LLC ($2.19M), Pictet Asset Management Holding SA ($1.25M), Orbimed Advisors LLC ($1.19M), and State Street Corp ($910.60K).

Institutional investors have sold a total of 39,007,103 shares in the last 24 months. This volume of shares sold represents approximately $2.70B in transactions.